Navigation Links
Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)
Date:4/23/2009

ion for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo poor-risk AML. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin(TM) (laromustine) Injection (formerly Cloretazine (VNP40101M)), delays in the regulatory approval process, particularly for Onrigin(TM) (laromustine) Injection, including possible delays in the FDA's review process beyond our expectation for approval in December 2009, delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not confirmed by safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2008, and "Risk Factors" in Vion's Post-Effective Amendments on Form S-1 Registrat
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009
2. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
3. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
4. Genesis Pharmaceuticals Announces the Launch of Three TCM Products
5. Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research
6. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
7. Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
8. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2009 Financial Results
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Worth, FL (PRWEB) July 23, 2014 ... take place Aug. 10-16, Millennium Treatment Group is providing ... abuse has existed in society ever since man first ... wine. Substance abuse treatment has existed since shortly thereafter. ... recognizing a problem and then developing a way to ...
(Date:7/23/2014)... July 24, 2014) If past experience is anything ... are about to get a lot more recognition for ... on the books allowing NPs to provide primary care ... care and better relationships with physicians and administrators, compared ... from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... a suspicious skin lesion is painful or itchy may ... be cancerous, according to a new study headed by ... at Temple University School of Medicine. , The study, ... 23, 2014, found that nearly 36. 9 percent of ... percent involve pain. Non-melanoma skin cancers specifically, basal ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Home ... in-home care for seniors, is proud to announce the ... featuring experts in a wide range of health and ... social worker and award-winning author Nancy Kriseman, and will ... ways to prevent burnout by becoming more self-aware. In ...
(Date:7/23/2014)... July 23, 2014 (HealthDay News) -- Regularly checking the ... stroke, researchers report. "Screening pulse is the method ... over age 65 who have never had a stroke. ... noninvasive and easy way to identify people who might ... said study author Dr. Bernd Kallmunzer, of Erlangen University ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:New York law offers nurses more recognition, responsibility 2Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2
... Supplier of the Year by UHC and Novation for ... Consortium (UHC) and Novation, the healthcare industry,s leading contracting ... Incorporated (NYSE: OMX ), a ... 2009 recipient of UHC Service Excellence Supplier Award most ...
... Joseph,s Hospital in Tampa Named One of the ... St. Joseph,s Hospital, a member of BayCare ... the leading hospitals in the United States, in a study ... May/June issue of AARP The Magazine. Consumers, Checkbook is ...
... UC San Diego School of Medicine and the Moores UCSD ... system cell thought to be part of the first line ... spread. They have found that when these cells, known as ... cancer is more likely to spread to the lungs. ...
... the medical literature by a panel of experts at ... held this month in Phoenix concluded that there is ... greatest number of transfusions currently being given to patients. ... between red blood cell transfusions and higher rates of ...
... Abstract #5637DENVER, April 22 Scientists from ... Detroit presented data today at the American ... 2009 that signifies exciting research advancements in ... of breast cancer.(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Researchers ...
... and Wellness and Reducing Common and Costly Chronic Disease ... to Senate and House LeadershipWASHINGTON, April 22 More ... Disease (PFCD) - an organization representing some of the ... on leaders in Congress to encourage updates in the ...
Cached Medicine News:Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3Health News:Baycare Health System Hospital Earns National Recognition 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2Health News:Blood transfusions and outcomes 2Health News:Blood transfusions and outcomes 3Health News:Blood transfusions and outcomes 4Health News:Karmanos Cancer Institute Researchers Provide New Hope for Breast Cancer Treatment 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 3Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 4Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 5Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 6Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 7
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... , July 23, 2014 Research and ... Electrocardiograph (ECG) Market by Product, End-user & by Lead ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... segmented into three major segments, namely, holter monitor, resting, ... was valued at $3,683 million in 2013 and is ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- The Centers for Medicare & Medicaid Services ... Improvement Organization (QIN-QIO) contract to a partnership led by ... August 1, WVMI will launch Quality Insights Quality Innovation ... Pennsylvania , Delaware , ... Network will engage providers and the community in multiple, ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: